1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (713) 745-0736
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas
Article first published online: 18 SEP 2006
DOI: 10.1002/cncr.22219
Copyright © 2006 American Cancer Society
Additional Information
How to Cite
Akyurek, N., Ren, Y., Rassidakis, G. Z., Schlette, E. J. and Medeiros, L. J. (2006), Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas. Cancer, 107: 1844–1851. doi: 10.1002/cncr.22219
Publication History
- Issue published online: 3 OCT 2006
- Article first published online: 18 SEP 2006
- Manuscript Revised: 20 JUL 2006
- Manuscript Accepted: 20 JUL 2006
- Manuscript Received: 7 MAY 2006
Funded by
- The Scientific and Technical Research Council of Turkey (TUBITAK)
REFERENCES
- 1, . Overview of cell death signaling pathways. Cancer Biol Ther. 2005; 4: 139–163.
- 2, , , et al. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol. 2004; 26: 82–97.
- 3, . Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 2002; 109( Suppl): S97–107.
- 4, , . An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol. 1993; 67: 2168–2174.
- 5, , , et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996; 379: 349–353.
- 6, . Caspases: enemies within. Science. 1998; 28: 1312–1316.
- 7, , , et al. Neutralization of Smac/DIABLO by inhibitor of apoptosis proteins (IAPs): a caspase-independent mechanism for apoptotic inhibition. J Biol Chem. 2004; 279: 51082–51090.
- 8, , , et al. Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc Natl Acad Sci U S A. 1999; 96: 10170–10175.
- 9, , , et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998; 396: 580–584.
- 10, , , et al. IAP supression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol. 2002; 22: 1754–1766.
- 11. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 2004; 64: 7183–7190.
- 12, , , et al. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J Clin Invest. 2006; 116: 174–181.
- 13, , , et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 2000; 96: 1921–1925.
- 14, , , et al. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol. 2004; 1: 1682–1688.
- 15
- 16, , . The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol. 2004; 14: 231–243.
- 17JaffeES, HarrisNL, SteinH, et al. (Eds). World Health Organization classification of tumors, pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2001.
- 18, , , et al. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol. 2004; 17: 954–961.
- 19, , , et al. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections. Am J Clin Pathol. 2002; 118: 328–334.
- 20, , , et al. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma. Leukemia. 2005; 19: 1663–1669.
- 21, , , et al. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP anti-sense oligonucleotides against multidrug-resistance TCC in vitro. Int J Cancer. 2003; 103: 29–37.Direct Link:
- 22, , , et al. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res. 2003; 9: 2826–2836.
- 23, , , et al. Expression of C-IAP1, C-IAP2, and SURVIVIN discriminates different types of lymphoid malignancies. Br J Haematol. 2005; 130: 852–859.Direct Link:
- 24, . Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med. 2003; 127: 1148–1160.
- 25, , , et al. t(3;14) (p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005; 19: 652–658.
- 26, , , et al. Nuclear factor (NF)-κb regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis alpha-induced apoptosis. J Exp Med. 1998; 188: 211–216.
- 27, , , et al. XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells. J Exp Med. 2003; 198: 341–347.